A complex approach to the treatment of arteriovenous IV-V degree malformations according to Spetzler‒Martin scale. Clinical case
Abstract
Four therapeutic approaches have been developed for the treatment of arteriovenous malformations (AVMs): microsurgery, radiosurgery, embolization, and conservative treatment. The lack of consensus regarding the choice of treatment method and the different specializations of the doctor who are onvolved to the patient with AVM often determine the wrong treatment strategy. We performed a prospective analysis of the results of AVM of the IV degree according to Spetzler‒Martin scale, 4–5 points on the Buffalo scale complex treatment, based on clinical and tomographic data after the use of partial endovascular embolization and radical microsurgical removal of the AVM node assisted by cell saving technology. According to cerebral angiography 4 months follow-up there is no visible AVM vessels, the malformation was completely resected.
Treatment of large and giant AVMs (IV and V degrees according to the Spetzler‒Martin scale) requires tailored surgical treatment approache using endovascular, microsurgical and radiosurgical techniques, but in many cases without achieving a radical result. The use of cell saver technology is necessary to reduce the risks of intraoperative complications associated with blood loss during microsurgical intervention, and enables radical removal of the AVM and recovery of the patient. The role of cell saver technology is crucial in vascular microsurgical interventions, which are often accompanied by a significant volume of blood loss, ensuring rapid autologous hemotransfusion and restoration of circulating blood volume. Endovascular embolization is a necessary step to reduce the risks of intraoperative complications during microsurgical intervention, which, together with the use of cell saver technology, makes it possible to achieve radical AVM removal and patient recovery.
Downloads
References
Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2013;118(2):437-43. doi: 10.3171/2012.10.JNS121280.
Sahlein DH, Mora P, Becske T, et al. Features predictive of brain arteriovenous malformation hemorrhage: extrapolation to a physiologic model. Stroke. 2014;45(7):1964-70. doi: 10.1161/STROKEAHA.114.005170.
Link TW, Winston G, Schwarz JT, et al. Treatment of unruptured brain arteriovenous malformations: a single-center experience of 86 patients and a critique of the a randomized trial of unruptured brain arteriovenous malformations (ARUBA) trial. World Neurosurg. 2018;120:e1156-62. doi:10.1016/j.wneu.2018.09.025.
Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA trial (a randomized trial of unruptured brain arteriovenous malformation)-eligible unruptured brain arteriovenous malformations. Stroke. 2017;48:136-44. doi:10.1161/STROKEAHA.116.014660.
Enjolras O, Wassef M, Chapot R. Color atlas of vascular tumors and vascular malformations. 1st ed. Cambridge; New York: Cambridge University Press; 2007. ISBN 978-0-521-84851-0
Yakes W, Baumgartner I. Interventional treatment of arterio-venous malformations. Gefässchirurgie. 2014;19:325-30. Doi: 10.1007/s00772-013-1303-9
Berman MF, Sciacca RR, Pile-Spellman J, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2):389-96; discussion 397. doi: 10.1097/00006123-200008000-00023.
Fukuda K, Majumdar M, Masoud H, et al. Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages. J Neurointerv Surg. 2017 Jul;9(7):664-8. doi: 10.1136/neurintsurg-2016-012485.
Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly ES Jr. Epidemiology and natural history of arteriovenous malformations. Neurosurg Focus 2001;11(5):e1. doi: 10.3171/foc.2001.11.5.2.
Yakes WF, Yakes AM. Classification of arteriovenous malformation and therapeutic implication In: Mattassi R, Loose DA, Vaghi M, eds. Hemangiomas and vascular malformations. Milan: Springer; 2015. P. 263-276. doi: 10.1007/978-88-470-5673-2_33.
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476-83. doi: 10.3171/jns.1986.65.4.0476.
Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations: clinical article. J Neurosurg. 2011;114(3):842-9. doi: 10.3171/2010.8.JNS10663.
Bervini D, Morgan MK, Ritson EA, Heller G. Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. J Neurosurg. 2014;121(4):878-90. doi: 10.3171/2014.7.JNS132691.
Cockroft KM, Jayaraman MV, Amin-Hanjani S, Der-deyn CP, McDougall CG, Wilson JA. A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations’ (ARUBA’s) trial design challenges notions of external validity. Stroke. 2012;43(7):1979-81. doi: 10.1161/STROKEAHA.112.652032.
Solomon R, Connolly ES. Arteriovenous malformations of the brain. N Engl J Med. 2017;377:497-8. doi: 10.1056/NEJMc1707399.
Pierot L, Januel AC, Herbreteau D, et al. Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective multicentre study. Interv Neuroradiol. 2013;23:2838-45. doi:10.1007/s00330-013-2870-6.
Söderman M, Andersson T, Karlsson B, Wallace MC, Edner G. Management of patients with brain arteriovenous malformations. Eur J Radiol. 2003;46(3):195-205. doi: 10.1016/s0720-048x(03)00091-3.
Young WL, Kader A, Ornstein E, et al. Cerebral hyperemia after arteriovenous malformation resection is related to “breakthrough” complications but not to feeding artery pressure. Neurosurgery. 1996;38:1085-93; discussion 1093-5. doi: 10.1097/00006123-199606000-00005.
Starke RM, Komotar RJ, Otten ML, et al. Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke. 2009;40(8):2783-90. doi: 10.1161/STROKEAHA.108.539775.
Penn DL, Wu KC, Presswood KR, et al. General principles for preoperative planning and microsurgical treatment of pediatric brain arteriovenous malformations: 2-dimensional operative video. Oper Neurosurg (Hagerstown, MD) 2019;16:E114. doi: 10.1093/ons/opy206.
Tong X, Wu J, Cao Y, Zhao Y, Wang S, Zhao J. Microsurgical outcome of unruptured brain arteriovenous malformations: a single-center experience. World Neurosurg. 2017;99:644-55. doi: 10.1016/j.wneu.2016.12.088.
Rohn B, Hänggi D, Etminan N, Turowski B, Steiger HJ. Relief of epilepsy and headache and quality of life after microsurgical treatment of unruptured brain AVM — audit of a single-center series and comprehensive review of the literature. Neurosurg Rev. 2017;40:59-65. doi: 10.1007/s10143-016-0750-7.
Lasjaunias P, Piske R, Terbrugge K, Willinsky R. Cerebral arteriovenous malformations (C. AVM) and associated arterial aneurysms (AA): analysis of 101 C. AVM cases, with 37 AA in 23 patients. Acta Neurochir (Wien). 1988;91(1-2):29-36. doi: 10.1007/BF01400524.
Redekop G, TerBrugge K, Montanera W, Willinsky R. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg. 1998;89(4):539-46. doi: 10.3171/jns.1998.89.4.0539.
Shcheglov DV, Bortnik IM, Svyrydiuk OYe, Konotopchyk SV. Vypadky poyednannya arteriovenoznykh malformatsiy ta mnozhynnykh anevryzm sudyn holovnoho mozku. Endovaskulyarna neyrorenthenokhirurhiya. 2016;1(15):41-9. (In Ukrainian)
This work is licensed under a Creative Commons Attribution 4.0 International License.
